Femasys Shareholders Approve Reverse Split and Financing Plans

The latest announcement is out from Femasys ( (FEMY) ).

At a special meeting of stockholders held on April 29, 2026, Femasys Inc. shareholders approved an amendment to the company’s certificate of incorporation authorizing a reverse stock split of its common shares at a ratio between 1-for-2 and 1-for-25, to be implemented at the board’s discretion any time before May 1, 2027. The company’s investors also approved the potential issuance of more than 19.99% of its outstanding common stock upon conversion of senior secured convertible notes and exercise of multiple warrant series at prices that may fall below Nasdaq’s minimum, enabling Femasys to proceed with its financing arrangements without breaching Nasdaq listing rules, while an adjournment proposal was rendered unnecessary by the favorable votes.

The most recent analyst rating on (FEMY) stock is a Buy with a $3.00 price target. To see the full list of analyst forecasts on Femasys stock, see the FEMY Stock Forecast page.

Spark’s Take on FEMY Stock

According to Spark, TipRanks’ AI Analyst, FEMY is a Neutral.

The score is primarily constrained by weak financial performance—persistent losses, deeply negative cash generation, and limited evidence of near-term self-funding—despite improved leverage. Technicals also remain bearish with the stock below major moving averages and a negative MACD, while valuation support is limited by negative earnings. Corporate events are mixed, with an execution-positive COO hire offset by ongoing Nasdaq compliance risk.

To see Spark’s full report on FEMY stock, click here.

More about Femasys

Femasys Inc. operates in the healthcare sector as a medical technology company focused on women’s health. The company develops and commercializes minimally invasive devices and treatments targeting reproductive health conditions, serving patients and providers in the gynecological and fertility care markets.

Average Trading Volume: 511,760

Technical Sentiment Signal: Sell

Current Market Cap: $23.62M

For an in-depth examination of FEMY stock, go to TipRanks’ Overview page.